Search details
1.
19S Proteasome Subunits as Oncogenes and Prognostic Biomarkers in FLT3-Mutated Acute Myeloid Leukemia (AML).
Int J Mol Sci
; 23(23)2022 Nov 23.
Article
in English
| MEDLINE | ID: mdl-36498916
2.
Ethnic and border differences on blood cancer presentation and outcomes: A Texas population-based study.
Cancer
; 127(7): 1068-1079, 2021 04 01.
Article
in English
| MEDLINE | ID: mdl-33616915
3.
Energy metabolism and drug response in myeloid leukaemic stem cells.
Br J Haematol
; 186(4): 524-537, 2019 08.
Article
in English
| MEDLINE | ID: mdl-31236939
4.
The prognostic value of 19S ATPase proteasome subunits in acute myeloid leukemia and other forms of cancer.
Front Med (Lausanne)
; 10: 1209425, 2023.
Article
in English
| MEDLINE | ID: mdl-37502358
5.
Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism.
Clin Transl Med
; 12(12): e1146, 2022 12.
Article
in English
| MEDLINE | ID: mdl-36536477
6.
Large Peritoneal Macrophages and Transitional Premonocytes Promote Survival during Abdominal Sepsis.
Immunohorizons
; 5(12): 994-1007, 2021 12 29.
Article
in English
| MEDLINE | ID: mdl-34965966
7.
Blood cancer health disparities in the United States Hispanic population.
Cold Spring Harb Mol Case Stud
; 7(2)2021 04.
Article
in English
| MEDLINE | ID: mdl-33593728
8.
26S Proteasome Non-ATPase Regulatory Subunits 1 (PSMD1) and 3 (PSMD3) as Putative Targets for Cancer Prognosis and Therapy.
Cells
; 10(9)2021 09 11.
Article
in English
| MEDLINE | ID: mdl-34572038
9.
Proteasome 26S subunit, non-ATPases 1 (PSMD1) and 3 (PSMD3), play an oncogenic role in chronic myeloid leukemia by stabilizing nuclear factor-kappa B.
Oncogene
; 40(15): 2697-2710, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33712704
Results
1 -
9
de 9
1
Next >
>>